Dexcom and ŌURA announce a strategic partnership to help millions of people improve their metabolic health through the integration of Dexcom glucose data with vital sign, sleep, stress, heart health ...

Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

With an increasing burden of diabetes in Singapore, digital innovations, research can help diabetics manage better. Read more ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

QRG Capital Management Inc. grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 8.6% in the 3rd quarter, ...

StockNews.com lowered shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research report report published on Saturday. A number of other analysts have also weighed in ...

Abbott competitor Dexcom also released a similar device for nondiabetics and diabetics who don’t take insulin over the summer called Stelo. Dexcom is selling its device for $99 for a one-month ...

Insulet ’s PODD robust execution to expand the Omnipod 5 platform globally is a tailwind. The company is also capitalizing on ...

Apple might disrupt the world of consumer tech once again. The US-based tech giant has reportedly developed a secret app that monitors blood sugar. The company is testing two tools to try and ...